July 12, 2021– The pharmaceutical giant Boehringer Ingelheim (BI), a manufacturer headquartered in Germany, is the latest company to announce it is cutting off discounts to safety-net hospitals participating in the 340B drug pricing program. If BI goes through with its threat on Aug. 1, it will become the seventh drug company to limit 340B discounts despite strong warnings by … [Read more...]
Faces of 340B: Meeting the Mission of a Healthier Community
April 29, 2021 – At MetroHealth in Cleveland, the health providers and the staff who support them work as one to meet the health system’s mission of “leading the way to a healthier you and a healthier community.” One of the key elements that helps turn these words into action is the 340B drug pricing program. MetroHealth is a system with four hospitals, more than 20 health … [Read more...]
Faces of 340B: Breathing Easier
October 16, 2020 – Dan Hargrave was struggling to breathe, and he and his physicians initially were not sure why. He had asthma as a child, but his doctors were not confident this was the cause. Eventually, Dan was diagnosed with chronic obstructive pulmonary disease (COPD). He did not know it at the time, but the 340B drug pricing program would be a key element of how he would … [Read more...]
Faces of 340B: Putting Insulin Within Reach
May 15, 2020 – Patient Debra Abercrumbie remembers that when she first came to MetroHealth in Cleveland, her hemoglobin A1C levels were “out of control,” and she would need to start managing them better if she were going to improve her health while living with her diabetes. Fortunately, MetroHealth had the medication assistance and care coordination that she required, in large … [Read more...]